Abstract
International Journal of Pharmacology and Clinical Sciences,2016,5,2,55-61.DOI:10.5530/ijpcs.5.2.4Published:June 2016Type:Review Article Authors:Monali Pradeep Vakharia, Vijay Ramakrishna Zad, Nishikant Nandlal Mankar, Pratik Pradeep Wadivkar, and Kalpana Unind Shah Author(s) affiliations:Monali Pradeep Vakharia1*, Vijay Ramakrishna Zad2, Nishikant Nandlal Mankar3, Pratik Pradeep Wadivkar1, Kalpana Unind Shah4 1Junior Resident, Department of Pharmacology, Dr. V. M. Govt. Medical College, Solapur, Maharashtra, INDIA. 2Associate Professor, Department of Pharmacology, Dr. V. M. Govt. Medical College, Solapur, Maharashtra, INDIA. 3Assisstant Professor, Department of Pharmacology, Dr. V. M. Govt. Medical College, Solapur, Maharashtra, INDIA. 4Professor and Head, Department of Pharmacology, Dr. V. M. Govt. Medical College, Solapur, Maharashtra, INDIA. Abstract:Diabetes is fast gaining the status of a potential epidemic in India with more than 62 million diabetic individuals currently diagnosed with the disease. There are atleast 10 different drug classes for the treatment of Type 2 diabetes mellitus (T2DM) but metformin is recommended as the initial medication for treatment of T2DM. Inter-individual variability in response and few clinical or biomarker predictors of response reduces its optimal use. Personalized medicine promises a path for individually optimized treatment, but realizing this promise will require a more comprehensive characterization of disease and drug response. As per American Medical Association, pharmacogenomics is the study of genetic variations that influence individual response to drugs. Knowing whether a patient carries any of these genetic variations can help prescribers individualize drug therapy, decrease the chance for adverse drug events, and increase the effectiveness of drugs. There are variety of genes controlling metformin transport in the body, for eg- SLC22A1, SLC22A2, SLC22A3, SLC22A4 etc. The purpose of this review article is to explain in brief pharmacogenomics of metformin and its application and practical hurdles in its translation. Keywords:Diabetes Mellitus, Metformin, Personalised medicine, Pharmacogenomics, SLC2A4View:PDF (523.32 KB) PDFClick here to download the PDF file. Images Metformin Pharmacodynamics
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Pharmacology and Clinical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
